Three independent yearly analyses of the spectrum and potency of metronidazole: a multicenter study of 1,108 contemporary anaerobic clinical isolates.


To comply with ongoing United States Food and Drug Administration (FDA) recommendations about the validation of prescribing information, in each of three years (1994, 1996, 1997) at six medical centers, metronidazole was tested against > or = 50 strains of a range of contemporary anaerobic clinical bacteria. Species having > or = 90% susceptibility (MIC… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.